Omicron-specific mRNA-based booster vaccine launched
GEMCOVAC-OM is India's first home-grown mRNA Covid vaccine
Source: theweek.in
Gemcovac Om News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gemcovac Om. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gemcovac Om Today - Breaking & Trending Today
gemcovac-om price: mRNA booster vaccine Gemcovac-OM for Omicron launched at Rs 2,292/dose. Who can take and precautions
Gemcovac-OM, the booster vaccine for Omicron from Emcure's subsidiary Gennova, had recently received the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). Individuals above 18 years and who have received either Covaxin or Covishield as primary vaccination can take it as a booster for active immunization for the prevention of COVID-19.
Source: indiatimes.com
Union minister Jitendra Singh launches Omicron-specific vaccine for Covid | Latest News India
A few days ago, this vaccine got the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). | Latest News India
Source: hindustantimes.com
Govt launches Gemovac-OM, India's first Omicron-specific mRNA booster vaccine
The vaccine has been developed using the indigenous platform technology by Gennova, with funding support from Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Counci
Source: livemint.com
India's first mRNA-based Omicron-specific booster vaccine from Pune-based Gennova gets DCGI approval
Gennova Biopharmaceuticals' mRNA Covid-19 booster vaccine, 'Gemcovac Om', has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'.
Source: hindustantimes.com